{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:37:13Z","timestamp":1792654633686,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.smim.2020.101433","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T04:16:44Z","timestamp":1607573804000},"page":"101433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":201,"special_numbering":"C","title":["Outer membrane vesicle vaccines"],"prefix":"10.1016","volume":"50","author":[{"given":"Francesca","family":"Micoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.smim.2020.101433_bib0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"7736","key":"10.1016\/j.smim.2020.101433_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/d41586-018-07758-3","article-title":"Vaccine candidates for poor nations are going to waste","volume":"564","author":"Kaslow","year":"2018","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.smim.2020.101433_bib0015","doi-asserted-by":"crossref","first-page":"12307","DOI":"10.1073\/pnas.1400473111","article-title":"Vaccines against poverty","volume":"111","author":"MacLennan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1579","key":"10.1016\/j.smim.2020.101433_bib0020","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1098\/rstb.2011.0075","article-title":"Twenty-first century vaccines, Philosophical transactions of the Royal Society of London","volume":"366","author":"Rappuoli","year":"2011","journal-title":"Series B, Biological sciences"},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20182160","article-title":"Vaccines: An achievement of civilization, a human right, our health insurance for the future","volume":"216","author":"Rappuoli","year":"2019","journal-title":"J. Exp. Med."},{"issue":"1645","key":"10.1016\/j.smim.2020.101433_bib0030","article-title":"The contribution of vaccination to global health: past, present and future, Philosophical transactions of the Royal Society of London","volume":"369","author":"Greenwood","year":"2014","journal-title":"Series B, Biol. Sci."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800376","article-title":"Emerging technologies for low-cost, rapid vaccine manufacture","volume":"14","author":"Kis","year":"2019","journal-title":"Biotechnol. J."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0040","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41467-019-08853-3","article-title":"Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage","volume":"10","author":"Hendriksen","year":"2019","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.smim.2020.101433_bib0045","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1073\/pnas.1717157115","article-title":"Antimicrobial resistance and the role of vaccines","volume":"115","author":"Bloom","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"10.1016\/j.smim.2020.101433_bib0050","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1073\/pnas.1717160115","article-title":"Technologies to address antimicrobial resistance","volume":"115","author":"Baker","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.smim.2020.101433_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: an update","volume":"323","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program","volume":"74","author":"O\u2019Ryan","year":"2014","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.smim.2020.101433_bib0070","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.00498-06","article-title":"Outer membrane vesicle production by Escherichia coli is independent of membrane instability","volume":"188","author":"McBroom","year":"2006","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00221287-49-1-1","article-title":"Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae","volume":"49","author":"Chatterjee","year":"1967","journal-title":"J. Gen. Microbiol."},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0085","first-page":"605","article-title":"Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions, Nature reviews","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0090","first-page":"13","article-title":"Types and origins of bacterial membrane vesicles, Nature reviews","volume":"17","author":"Toyofuku","year":"2019","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.141.2.297","article-title":"Pili on meningococci from primary cultures of nasopharyngeal carriers and cerebrospinal fluid of patients with acute disease","volume":"141","author":"DeVoe","year":"1975","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.smim.2020.101433_bib0100","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/JB.00257-06","article-title":"Membrane vesicles: an overlooked component of the matrices of biofilms","volume":"188","author":"Schooling","year":"2006","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0105","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/JB.01333-08","article-title":"Three-dimensional macromolecular organization of cryofixed Myxococcus xanthus biofilms as revealed by electron microscopic tomography","volume":"191","author":"Palsdottir","year":"2009","journal-title":"J. Bacteriol."},{"issue":"14","key":"10.1016\/j.smim.2020.101433_bib0110","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/jb.177.14.3998-4008.1995","article-title":"Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion","volume":"177","author":"Kadurugamuwa","year":"1995","journal-title":"J. Bacteriol."},{"issue":"11","key":"10.1016\/j.smim.2020.101433_bib0115","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/AEM.04248-13","article-title":"Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation","volume":"80","author":"Fulsundar","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0120","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/AAC.00929-10","article-title":"Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii","volume":"55","author":"Rumbo","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.smim.2020.101433_bib0125","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol. J."},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0130","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0135","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/pr301208g","article-title":"Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines","volume":"12","author":"van de Waterbeemd","year":"2013","journal-title":"J. Proteome Res."},{"issue":"18","key":"10.1016\/j.smim.2020.101433_bib0140","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/JB.180.18.4872-4878.1998","article-title":"Escherichia coli tol-pal mutants form outer membrane vesicles","volume":"180","author":"Bernadac","year":"1998","journal-title":"J. Bacteriol."},{"issue":"Pt 10","key":"10.1016\/j.smim.2020.101433_bib0145","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1099\/mic.0.28237-0","article-title":"Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence","volume":"151","author":"Dubuisson","year":"2005","journal-title":"Microbiology"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hel.12196","article-title":"Increased outer membrane vesicle formation in a Helicobacter pylori tolB mutant","volume":"20","author":"Turner","year":"2015","journal-title":"Helicobacter"},{"issue":"15","key":"10.1016\/j.smim.2020.101433_bib0155","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.vaccine.2016.02.018","article-title":"Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain","volume":"34","author":"Mitra","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0160","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/JB.187.10.3359-3368.2005","article-title":"Defective O-antigen polymerization in tolA and pal mutants of Escherichia coli in response to extracytoplasmic stress","volume":"187","author":"Vines","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.smim.2020.101433_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.244","article-title":"NlpI-mediated modulation of outer membrane vesicle production through peptidoglycan dynamics in Escherichia coli","author":"Schwechheimer","year":"2015","journal-title":"Microbiologyopen"},{"issue":"9","key":"10.1016\/j.smim.2020.101433_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139200","article-title":"Genome-wide assessment of outer membrane vesicle production in Escherichia coli","volume":"10","author":"Kulp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2020.101433_bib0175","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1038\/ncomms10515","article-title":"A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria","volume":"7","author":"Roier","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/jb.136.1.280-285.1978","article-title":"Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins","volume":"136","author":"Sonntag","year":"1978","journal-title":"J. Bacteriol."},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065157","article-title":"Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis","volume":"8","author":"van de Waterbeemd","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0190","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1099\/mic.0.000227","article-title":"Dissection of the function of the RmpM periplasmic protein from Neisseria meningitidis","volume":"162","author":"Maharjan","year":"2016","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1574-6968.12463","article-title":"Enterohemorrhagic Escherichia coli OmpT regulates outer membrane vesicle biogenesis","volume":"355","author":"Premjani","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0200","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00940-16","article-title":"LPS remodeling triggers formation of outer membrane vesicles in Salmonella","volume":"7","author":"Elhenawy","year":"2016","journal-title":"MBio"},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0205","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/JB.00016-12","article-title":"Biogenesis of outer membrane vesicles in Serratia marcescens is thermoregulated and can be induced by activation of the Rcs phosphorelay system","volume":"194","author":"McMahon","year":"2012","journal-title":"J. Bacteriol."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0210","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1534\/g3.114.014381","article-title":"A Shigella flexneri virulence plasmid encoded factor controls production of outer membrane vesicles","volume":"4","author":"Sidik","year":"2014","journal-title":"G3 Bethesda (Bethesda)"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0215","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1128\/IAI.73.4.2222-2231.2005","article-title":"Function of neisserial outer membrane phospholipase a in autolysis and assessment of its vaccine potential","volume":"73","author":"Bos","year":"2005","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"issue":"47","key":"10.1016\/j.smim.2020.101433_bib0225","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1016\/j.vaccine.2019.01.076","article-title":"Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification","volume":"37","author":"Gerritzen","year":"2019","journal-title":"Vaccine"},{"issue":"23-24","key":"10.1016\/j.smim.2020.101433_bib0230","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1007\/s00253-019-10163-z","article-title":"Continuous production of Neisseria meningitidis outer membrane vesicles","volume":"103","author":"Gerritzen","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/CVI.00023-16","article-title":"Toll-like receptor activation by generalized modules for membrane antigens from lipid a mutants of Salmonella enterica serovars typhimurium and enteritidis","volume":"23","author":"Rossi","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"36","key":"10.1016\/j.smim.2020.101433_bib0240","doi-asserted-by":"crossref","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","article-title":"Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants","volume":"289","author":"Rossi","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7242","key":"10.1016\/j.smim.2020.101433_bib0245","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0250","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1046\/j.1432-1327.2000.01204.x","article-title":"Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion","volume":"267","author":"Schromm","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0255","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.4049\/jimmunol.175.7.4669","article-title":"Molecular basis of reduced potency of underacylated endotoxins","volume":"175","author":"Teghanemt","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2020.101433_bib0260","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/md11093197","article-title":"Influence of lipid A acylation pattern on membrane permeability and innate immune stimulation","volume":"11","author":"Li","year":"2013","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/md11020363","article-title":"Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharides","volume":"11","author":"Han","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.smim.2020.101433_bib0270","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2015.00823","article-title":"A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles","volume":"6","author":"Leitner","year":"2015","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0275","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01382-12","article-title":"Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen","volume":"81","author":"Leitner","year":"2013","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0280","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/IAI.01108-08","article-title":"Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response","volume":"77","author":"Weynants","year":"2009","journal-title":"Infect. Immun."},{"issue":"30","key":"10.1016\/j.smim.2020.101433_bib0285","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0290","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115713","article-title":"Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice","volume":"9","author":"Mehta","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cmi.12231","article-title":"LOS oligosaccharide modification enhances dendritic cell responses to meningococcal native outer membrane vesicles expressing a non-toxic lipid A","volume":"16","author":"Jones","year":"2014","journal-title":"Cell. Microbiol."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0305","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect. Immun."},{"issue":"23","key":"10.1016\/j.smim.2020.101433_bib0310","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.vaccine.2014.03.068","article-title":"A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA)","volume":"32","author":"Koeberling","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0315","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0320","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \"Folkehelsa\": an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0325","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/iai.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.smim.2020.101433_bib0330","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2005.09.043","article-title":"Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control","volume":"24","author":"Thornton","year":"2006","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.smim.2020.101433_bib0335","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2011.06.120","article-title":"Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand","volume":"29","author":"Arnold","year":"2011","journal-title":"Vaccine"},{"issue":"10102","key":"10.1016\/j.smim.2020.101433_bib0340","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"issue":"8775","key":"10.1016\/j.smim.2020.101433_bib0345","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0350","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"Suppl 2","key":"10.1016\/j.smim.2020.101433_bib0355","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0360","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0365","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0370","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jinf.2015.05.006","article-title":"A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: a phase I clinical trial","volume":"71","author":"Marsay","year":"2015","journal-title":"J. Infect."},{"issue":"Suppl 2(0 2)","key":"10.1016\/j.smim.2020.101433_bib0375","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"issue":"5459","key":"10.1016\/j.smim.2020.101433_bib0380","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"51","key":"10.1016\/j.smim.2020.101433_bib0385","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1016\/j.vaccine.2013.09.044","article-title":"Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines","volume":"31","author":"Tunheim","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2020.101433_bib0390","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0395","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","article-title":"Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect. Immun."},{"issue":"1-2","key":"10.1016\/j.smim.2020.101433_bib0400","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","article-title":"Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0405","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0410","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.smim.2020.101433_bib0415","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.vaccine.2015.01.057","article-title":"A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice","volume":"33","author":"Pajon","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0420","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines","volume":"18","author":"Koeberling","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0425","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CVI.00403-08","article-title":"Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2","volume":"16","author":"Koeberling","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"31","key":"10.1016\/j.smim.2020.101433_bib0430","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine","volume":"28","author":"Zollinger","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066536","article-title":"Mutant native outer membrane vesicles combined with a serogroup a polysaccharide conjugate vaccine for prevention of meningococcal epidemics in Africa","volume":"8","author":"Pajon","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0440","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.vaccine.2015.12.034","article-title":"A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine","volume":"34","author":"Pajon","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0445","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870","volume":"192","author":"Hou","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0450","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.vaccine.2006.03.092","article-title":"Improved immunogenicity of a H44\/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870","volume":"25","author":"Koeberling","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0455","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","article-title":"Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin","volume":"198","author":"Koeberling","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0460","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.73.8.5031-5038.2005","article-title":"Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits","volume":"73","author":"Shoemaker","year":"2005","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.smim.2020.101433_bib0465","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/CVI.00070-12","article-title":"Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine","volume":"19","author":"Moran","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"35","key":"10.1016\/j.smim.2020.101433_bib0470","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.vaccine.2016.05.049","article-title":"Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.smim.2020.101433_bib0475","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2020.101433_bib0480","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2019.00683","article-title":"Exploitation of Neisseria meningitidis group B OMV vaccines against N. Gonorrhoeae to inform the development and deployment of effective gonorrhea vaccines","volume":"10","author":"Petousis-Harris","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0485","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/jiy609","article-title":"A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed factor H binding protein elicits gonococcal bactericidal antibodies","volume":"219","author":"Beernink","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0490","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol."},{"issue":"46","key":"10.1016\/j.smim.2020.101433_bib0495","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","article-title":"Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.smim.2020.101433_bib0500","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.vaccine.2013.05.001","article-title":"Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis","volume":"31","author":"Mitra","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0505","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8020160","article-title":"GMMA and glycoconjugate approaches compared in mice for the development of a vaccine against Shigella flexneri serotype 6","volume":"8","author":"Raso","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.smim.2020.101433_bib0510","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","article-title":"Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, intradermally and intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe","volume":"22","author":"Launay","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.smim.2020.101433_bib0515","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2017.01884","article-title":"A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a shigellosis-endemic country","volume":"8","author":"Obiero","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2020.101433_bib0520","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2019.00335","article-title":"Booster vaccination with GVGH Shigella sonnei 1790GAHB GMMA vaccine compared to single vaccination in unvaccinated healthy european adults: results from a phase 1 clinical trial","volume":"10","author":"Launay","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0525","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/21645515.2019.1606971","article-title":"Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis","volume":"15","author":"Cohen","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.smim.2020.101433_bib0530","doi-asserted-by":"crossref","first-page":"34776","DOI":"10.1038\/srep34776","article-title":"Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0535","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.vaccine.2016.11.089","article-title":"Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella","volume":"35","author":"De Benedetto","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0540","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02379-17","article-title":"IgG responses to Porins and lipopolysaccharide within an outer membrane-based vaccine against nontyphoidal Salmonella Develop at discordant rates","volume":"9","author":"Schager","year":"2018","journal-title":"MBio"},{"issue":"41","key":"10.1016\/j.smim.2020.101433_bib0545","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1073\/pnas.1807655115","article-title":"Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella","volume":"115","author":"Micoli","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0550","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1128\/IAI.00532-08","article-title":"Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice","volume":"76","author":"Schild","year":"2008","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0555","first-page":"212","article-title":"Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice","volume":"11","author":"Sedaghat","year":"2019","journal-title":"Iran. J. Microbiol."},{"issue":"10","key":"10.1016\/j.smim.2020.101433_bib0560","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/IAI.00398-10","article-title":"Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility","volume":"78","author":"Bishop","year":"2010","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0565","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.vaccine.2017.09.004","article-title":"Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions","volume":"36","author":"Adriani","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0570","doi-asserted-by":"crossref","first-page":"e42664","DOI":"10.1371\/journal.pone.0042664","article-title":"Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice","volume":"7","author":"Roier","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0575","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","article-title":"Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity","volume":"14","author":"Raeven","year":"2015","journal-title":"J. Proteome Res."},{"issue":"28","key":"10.1016\/j.smim.2020.101433_bib0580","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2016.04.079","article-title":"Characterization of the immune response induced by pertussis OMVs-based vaccine","volume":"34","author":"Bottero","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0585","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2013.12.048","article-title":"Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes","volume":"32","author":"Gaillard","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0590","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1021\/pr1009756","article-title":"M.L. Van Hoek, Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine","volume":"10","author":"Pierson","year":"2011","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0595","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.01008-13","article-title":"Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway","volume":"81","author":"Zhao","year":"2013","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0600","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2018.01.034","article-title":"Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2020.101433_bib0605","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1038\/emm.2015.59","article-title":"Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity","volume":"47","author":"Lee","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.smim.2020.101433_bib0610","article-title":"Nanoparticle reinforced bacterial outer-membrane vesicles effectively prevent fatal infection of carbapenem-resistant Klebsiella pneumoniae","volume":"24","author":"Wu","year":"2020","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0615","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1074\/jbc.M307628200","article-title":"Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles","volume":"279","author":"Kesty","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2020.101433_bib0620","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","author":"Schild","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.smim.2020.101433_bib0625","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen","volume":"3","author":"Fantappie","year":"2014","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0630","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.smim.2020.101433_bib0635","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v2i0.20181","article-title":"Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro","volume":"2","author":"Bartolini","year":"2013","journal-title":"J. Extracell. Vesicles"},{"issue":"18","key":"10.1016\/j.smim.2020.101433_bib0640","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1128\/AEM.01941-14","article-title":"Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach","volume":"80","author":"Daleke-Schermerhorn","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0645","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.smim.2020.101433_bib0650","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.vaccine.2009.08.106","article-title":"Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses","volume":"27","author":"Schroeder","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0655","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"17","key":"10.1016\/j.smim.2020.101433_bib0660","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0665","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with <em>Salmonella enterica<\/em> serovar typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with <em>Streptococcus pneumoniae<\/em>","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.smim.2020.101433_bib0670","article-title":"Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2020.101433_bib0675","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen","volume":"3","author":"Fantappi\u00e8","year":"2014","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.smim.2020.101433_bib0680","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/bs.mie.2017.06.032","article-title":"Glycoengineered outer membrane vesicles as a platform for vaccine development","volume":"597","author":"Valguarnera","year":"2017","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.smim.2020.101433_bib0685","article-title":"Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies","author":"Chen","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0690","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.chembiol.2016.05.014","article-title":"Immunization with outer membrane vesicles displaying designer glycotopes yields class-switched, glycan-specific antibodies","volume":"23","author":"Valentine","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.smim.2020.101433_bib0695","doi-asserted-by":"crossref","first-page":"24931","DOI":"10.1038\/srep24931","article-title":"Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines","volume":"6","author":"Price","year":"2016","journal-title":"Sci. Rep."},{"issue":"44","key":"10.1016\/j.smim.2020.101433_bib0700","doi-asserted-by":"crossref","first-page":"24963","DOI":"10.1021\/acsami.5b08811","article-title":"Bacterial nanobioreactors--Directing enzyme packaging into bacterial outer membrane vesicles","volume":"7","author":"Alves","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.smim.2020.101433_bib0705","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2020.00890","article-title":"Combining protein ligation systems to expand the functionality of semi-synthetic outer membrane vesicle nanoparticles","volume":"11","author":"van den Berg van Saparoea","year":"2020","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0710","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0715","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030540","article-title":"GMMA is a versatile platform to design effective multivalent combination vaccines","volume":"8","author":"Micoli","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0720","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrp.2014.10.012","article-title":"Preparation and evaluation of a new lipopolysaccharide-based conjugate as a vaccine candidate for brucellosis","volume":"6","author":"Siadat","year":"2015","journal-title":"Osong Public Health Res. Perspect."},{"issue":"Pt 3","key":"10.1016\/j.smim.2020.101433_bib0725","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BA20060041","article-title":"Optimization of the conjugation method for a serogroup B\/C meningococcal vaccine","volume":"45","author":"Fukasawa","year":"2006","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0730","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124416","article-title":"OMV vaccines and the role of TLR agonists in immune response","volume":"21","author":"Mancini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2020.101433_bib0735","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.05.033","article-title":"Orchestrating immune responses: how size, shape and rigidity affect the immunogenicity of particulate vaccines","volume":"234","author":"Benne","year":"2016","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.smim.2020.101433_bib0740","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.smim.2020.101433_bib0745","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2020.101433_bib0750","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0755","first-page":"4092","article-title":"Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses, Journal of immunology (Baltimore","volume":"190","author":"Kim","year":"2013","journal-title":"Md. : 1950)"},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0760","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1128\/IAI.68.12.6917-6923.2000","volume":"68","author":"Lapinet","year":"2000","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0765","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/IAI.00703-13","article-title":"Human lung tissue explants reveal novel interactions during Legionella pneumophila infections","volume":"82","author":"J\u00e4ger","year":"2014","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.smim.2020.101433_bib0770","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.micinf.2006.05.001","article-title":"Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response","volume":"8","author":"Bauman","year":"2006","journal-title":"Microbes Infect."},{"issue":"5396","key":"10.1016\/j.smim.2020.101433_bib0775","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0780","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2009.09.018","article-title":"Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer","volume":"31","author":"Kang","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.smim.2020.101433_bib0785","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4049\/jimmunol.167.4.1882","article-title":"Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression","volume":"167","author":"Gewirtz","year":"2001","journal-title":"J. Immunol."},{"issue":"6832","key":"10.1016\/j.smim.2020.101433_bib0790","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"issue":"6813","key":"10.1016\/j.smim.2020.101433_bib0795","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0800","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1099\/mic.0.26841-0","article-title":"DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential","volume":"150","author":"Renelli","year":"2004","journal-title":"Microbiology (Reading, Engl.)"},{"issue":"6","key":"10.1016\/j.smim.2020.101433_bib0805","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.1200898","article-title":"Cutting edge: TLR13 is a receptor for bacterial RNA","volume":"189","author":"Hidmark","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015692","article-title":"Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis","volume":"5","author":"Fransen","year":"2010","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.smim.2020.101433_bib0815","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.vaccine.2009.01.109","article-title":"Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles","volume":"27","author":"Durand","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0820","first-page":"5939","article-title":"Agonists of Toll-Like Receptors 3, 4, 7, and 9 are Candidates for Use as Adjuvants in an Outer Membrane Vaccine against Neisseria meningitidis","volume":"75","author":"Fransen","year":"2007","journal-title":"Serogroup B"},{"issue":"12","key":"10.1016\/j.smim.2020.101433_bib0825","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1086\/498167","article-title":"Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms","volume":"192","author":"Opal","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"46","key":"10.1016\/j.smim.2020.101433_bib0830","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1016\/j.vaccine.2011.08.102","article-title":"Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0835","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.vaccine.2005.07.064","article-title":"Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant","volume":"24","author":"Sardi\u00f1as","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2020.101433_bib0840","article-title":"Native outer membrane vesicle (nOMV)-antigen conjugates and use thereof","author":"Di Benedetto","year":"2018","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.smim.2020.101433_bib0845","article-title":"A multi-functionalized nOMV conjugates","author":"Alfini","year":"2019","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.smim.2020.101433_bib0850","article-title":"A Immunogenic conjugates and use thereof","author":"Alfini","year":"2018","journal-title":"PCT Int. Appl."},{"issue":"8","key":"10.1016\/j.smim.2020.101433_bib0855","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.vaccine.2016.01.019","article-title":"Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles","volume":"34","author":"Salverda","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.smim.2020.101433_bib0860","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.molpharmaceut.8b00901","article-title":"Exosome as a novel shuttle for delivery of therapeutics across biological barriers","volume":"16","author":"Das","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.smim.2020.101433_bib0865","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/AAC.47.9.2962-2965.2003","article-title":"Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1","volume":"47","author":"Allan","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.smim.2020.101433_bib0870","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7020046","article-title":"Bacterial outer membrane vesicles (OMVs)-based dual vaccine for influenza a H1N1 virus and MERS-CoV","volume":"7","author":"Shehata","year":"2019","journal-title":"Vaccines"},{"issue":"9-10","key":"10.1016\/j.smim.2020.101433_bib0875","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"Arigita","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.smim.2020.101433_bib0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181508","article-title":"Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1","volume":"12","author":"Marini","year":"2017","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.smim.2020.101433_bib0885","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1518311113","article-title":"Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies","volume":"113","author":"Chen","year":"2016","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232030049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232030049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:22:02Z","timestamp":1760916122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453232030049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":177,"alternative-id":["S104453232030049X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2020.101433","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outer membrane vesicle vaccines","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2020.101433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101433"}}